96373 ⎘
Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
Sub-classes:ACETYLATED RIBONUCLEIC ACIDS AND USES THEREOF
#2Polyol-Derived Compounds
#3Method for purifying sucralose-6-ester
#4Polyol-Derived Compounds
#5SUBSTITUTED ESTERS CONTAINING POLYOLS AND SACCHARIDES FOR TREATING HEPATOTOXICITY AND FATTY LIVER DISEASES
#6DEUTERATED NUCLEOSIDE COMPOUNDS AND USE THEREOF
#7METHOD FOR PURIFYING SUCRALOSE-6-ACETATE
#8TRITERPENE SAPONIN ANALOGUES
#9CRYSTAL FORMS OF GLUCOSAMINE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND USE THEREOF
#10APPLICATIONS OF ANALOGS OR DERIVATIVES OF SIALIC ACIDS
#11AMYLOID TARGETING AGENTS AND METHODS OF USING THE SAME
#12PENETRATING CRYOPROTECTION AGENTS AND METHODS OF MAKING AND USING SAME
#13PROTECTED TETRASACCHARIDES, THEIR PROCESS OF PREPARATION AND THEIR USE AS TRANSGLUCOSYLASE ACCEPTOR SUBSTRATES IN THE CHEMO-ENZYMATIC SYNTHESIS OF SHIGELLA FLEXNERI SPECIFIC OLIGOSACCHARIDES
#14DUALLY DERIVATIZED CHITOSAN NANOPARTICLES AND METHODS OF MAKING AND USING THE SAME FOR GENE TRANSFER IN VIVO
#15PRODUCTION APPARATUS AND PRODUCTION METHOD OF SUCROSE-6-ESTER
#16Acetylated ribonucleic acids and uses thereof
#17DEVICE AND METHOD FOR PREPARING SUCROSE-6-ESTER
#18METHOD FOR PREPARING SUCROSE-6-ESTER
#19PRODUCTION APPARATUS AND PRODUCTION METHOD OF SUCROSE-6-ESTER
#20Metabolic labeling and molecular enhancement of biological materials using bioorthogonal reactions
#21DEVICE AND METHOD FOR PRODUCING SUCROSE-6-ESTER
#22Triterpene saponin analogues
#23Sugar Chain and Compositions Thereof and Use Thereof in Prevention and/or Treatment of Coronavirus Infection
#24GLUCOSYL ESTERS FOR INFECTION SCREENING
#25LARGE SCALE PROCESS FOR PREPARING 1,2,4, 6-TETRA-O-ACETYL-3-AZIDO-3-DEOXY-D-GALACTOPYRANOSIDE
#26METHODS AND COMPOSITIONS FOR MAKING ANTIBODIES AND ANTIBODY DERIVATIVES WITH REDUCED CORE FUCOSYLATION
#27SYNTHETIC AGONISTS OF TLR4 RECEPTOR
#28Substituted esters containing polyols and saccharides for treating hepatotoxicity and fatty liver diseases
#29Crystalline forms of LNT
#30Nutritional supplements and therapeutic compositions comprising (r)-3- hydroxybutyrate derivatives
#31Alpha (1,2) fucosyltransferase syngenes for use in the production of fucosylated oligosaccharides
#32Processes and materials for the synthesis of sugar esters found in natural tobacco
#33PEROXIDE REMOVAL FROM DRUG DELIVERY VEHICLE
#34Amyloid targeting agents and methods of using the same
#35Use of UAP inhibitors to inhibit flux through the hexosamine biosynthetic pathway
#36BIOSYNTHESIS OF HUMAN MILK OLIGOSACCHARIDES IN ENGINEERED BACTERIA
#37Aminoglycosides and uses thereof in treating genetic disorders
#38Fluorinated N-acetyl glucosamine analogs and xylose derivatives
#39Potent sialyltransferase inhibitors
#40N-acylethanolamide derivatives and uses thereof
#41Therapeutic drug for neurodegenerative disease and application thereof
#42CARBOHYDRATE ESTERS AS INDUCERS FOR GENE EXPRESSION
#43Immunigenic alpha-branched trehalose-diesters
#44CONJUGATED ANTISENSE COMPOUNDS AND THEIR USE
#45Mofezolac derivatives as multi-functions selective COX-1 inhibitors
#46DETECTION OF OLIGOSACCHARIDES
#47TRITERPENE SAPONIN ANALOGUES
#48Crystalline forms of LNT
#49Triterpene saponin analogues
#50Microorganisms and methods for producing sialylated and n-acetylglucosamine-containing oligosaccharides
#51Derivatives of sobetirome
#52Protected tetrasaccharides, their process of preparation and their use as transglucosylase acceptor substrates in the chemo-enzymatic synthesis of specific oligosaccharides
#53Sialic acid analogs
#54Amyloid targeting agents and methods of using the same
#55Hybrid galactoside inhibitor of galectins
#56Thiosaccharide mucolytic agents
#57BIOSYNTHESIS OF HUMAN MILK OLIGOSACCHARIDES IN ENGINEERED BACTERIA
#58Aminoglycosides and uses thereof in treating genetic disorders
#59Dually derivatized chitosan nanoparticles and methods of making and using the same for gene transfer in vivo
#60Pattern forming method, under coating agent, and laminate
#61Substituted esters containing polyols and saccharides for treating hepatotoxicity and fatty liver diseases
#62Triazole antimicrobial derivative, pharmaceutical composition and use thereof
#63Peroxide removal from drug delivery vehicle
#64Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR
#65Liquid-liquid extraction of DMF
#66Prodrugs of Chlorokynurenines
#67Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation
#68GLA monotherapy for use in cancer treatment
#69N-acylethanolamide derivatives and uses thereof
#70Process for producing monosaccharides from chitin and/or chitosan by means of chemical and/or enzymatic hydrolysis and the uses thereof
#71Compositions and methods
#72Method for removing residual organic solvent from a crystalline oligosaccharide
#73Chemical synthesis method of serotype O51 O-antigen oligosaccharide
#74Aminoglycosides and uses thereof in treating genetic disorders
#75Crocins compounds and uses thereof
#76Fungal Trisaccharide Ester Compounds and Use Thereof in Preparing Agents for Preventing and Controlling Plant Fungal Diseases
#77Sialic acid analogs
#78Separation of oligosaccharides from fermentation broth
#79Composition, crocins active site, and uses thereof
#80Method for preparing sucralose-6-acetate in biphasic liquid-liquid system
#81Brain-targeting prodrug for AMPA receptor synergist, and pharmaceutical applications thereof
#82Regioselective silyl exchange of per-silylated oligosaccharides
#83METHOD FOR PRODUCING ALPHA-HALO-TETRAACYL-GLUCOSE
#84Separation of oligosaccharides from fermentation broth
#85Crystalline forms of LNT
#86Method of using carbohydrate esters as inducers for gene expression
#87Synthetic intermediate of 1-(2-deoxy-2-fluoro-4-thio-β-D-arabinofuranosyl)cytosine, synthetic intermediate of thionucleoside, and method for producing the same
#88Amyloid targeting agents and methods of using the same
#89PRODRUGS OF CHLOROKYNURENINES
#90Method of preparation of 6-azido-2,4-diacetamido-2,4,6-trideoxy-D-mannose
#91Crystal of 6′-sialyllactose sodium salt, and process for producing same
#92Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR
#93Neuraminidase Inhibitor Compounds, Compositions and Methods for the Use Thereof in Anti-Viral Treatments
#94Substituted esters containing polyols and saccharides for treating hepatotoxicity and fatty liver diseases
#95Biosynthesis of human milk oligosaccharides in engineered bacteria
#96Methods for the synthesis of functionalized nucleic acids
#97CATIONIC PEPTIDOPOLYSACCHARIDES WITH EXCELLENT BROAD- SPECTRUM ANTIMICROBIAL ACTIVITIES AND HIGH SELECTIVITY
#98Nutritional supplements and therapeutic compositions comprising (r)-3-hydroxybutyrate derivatives
#99Chlorination of sucrose-6-esters
#100Cell-permeable probes for identification and imaging of sialidases
#101Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation
#102Use of UAP inhibitors to inhibit flux through the hexosamine biosynthetic pathway
#103Thiosaccharide mucolytic agents
#104Oligonucleotide derivative, oligonucleotide construct using the same, and methods for producing them
#105Detection of oligosaccharides
#106Biosynthesis of human milk oligosaccharides in engineered bacteria
#107Microorganisms and methods for producing sialylated and N-acetylglucosamine-containing oligosaccharides
#1082,3-Fluorinated Glycosides as Neuraminidase Inhibitors and Their Use as Anti-Virals
#109Derivatives of sobetirome
#110Dually derivatized chitosan nanoparticles and methods of making and using the same for gene transfer in vivo
#111Separation of oligosaccharides from fermentation broth
#112Liquid-liquid extraction of DMF
#113Metabolic labeling and molecular enhancement of biological materials using bioorthogonal reactions
#114Hybrid galactoside inhibitor of galectins
#115Biosynthesis of human milk oligosaccharides in engineered bacteria
#116Chlorination of sucrose-6-esters
#117Biosynthesis of human milk oligosaccharides in engineered bacteria
#118Materials derived from fermentation-produced rhamnolipids and methods of production
#119Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR
#120Hamamelitannin analogues and uses thereof
#121Synthesis and composition of photodynamic therapeutic agents for the targeted treatment of cancer
#122Synthetic derivatives of MPL and uses thereof
#123Immunomodulating beta-1,6-D-glucans
#124Alpha (1,2) fucosyltransferase syngenes for use in the production of fucosylated oligosaccharides
#125Crystal forms of sialic acid or salt or solvate thereof
#126Oligosialic acid derivatives, methods of manufacture, and immunological uses
#127Synthesis of amphiphilic calixarene glycoside detergents and use of same for extracting and stabilizing native functional membrane proteins
#128Neuraminidase inhibitor compounds, compositions and methods for the use thereof in anti-viral treatments
#129Synthetic intermediate of 1-(2-deoxy-2-fluoro-4-thio-β-D-arabinofuranosyl)cytosine, synthetic intermediate of thionucleoside, and method for producing the same
#130PEROXIDE REMOVAL FROM DRUG DELIVERY VEHICLE
#131Process for the recovery of beta acetylfuranoside
#132Sialic acid analogs
#133Diversification of human milk oligosaccharides (HMOs) or precursors thereof
#134Glycans as functional cancer targets and antibodies thereto
#135Disaccharide intermediate and synthesis method thereof
#136Preparation of poly alpha-1,3-glucan esters and films therefrom
#137Derivatives of sobetirome
#138Organic acid glycoside contained in coffee beans
#139Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR
#140Regioselective silyl exchange of per-silylated oligosaccharides
#141Process for producing novel sialo-sugar chain
#142HYBRID SCFA-HYDROXYL-DERIVATIZED MONOSACCHARIDES, METHODS OF SYNTHESIS, AND METHODS OF TREATING DISORDERS
#143Therapeutic monosaccharide-based inhibitors of hexokinase and glucokinase for parasitic diseases, along with methods of their formation and use
#144Heterocyclic compounds and methods of their use
#145Aminoglycosides and uses thereof in treating genetic disorders
#1462,3-Fluorinated glycosides as neuraminidase inhibitors and their use as anti-virals
#147Thiosaccharide mucolytic agents
#148Microorganisms and methods for producing sialylated and N-acetylglucosamine-containing oligosaccharides
#149Synthetic intermediate of 1-(2-deoxy-2-fluoro-4-thio-β-D-arabinofuranosyl) cytosine, synthetic intermediate of thionucleoside, and method for producing the same
#150Short-chain fatty acid hexosamine analogs and their use in tissue engineering applications
#151METHOD FOR PRODUCING a-HALO-TETRAACYL-GLUCOSE
#152Method for producing pyrazoles, novel pyrazoles and applications thereof
#153GLA monotherapy for use in cancer treatment
#154Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation
#155Polymorphs of LNnT
#156Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR
#157Detection of oligosaccharides
#158Glycoconjugate synthesis
#159Cell-permeable probes for identification and imaging of sialidases
#160Non-enzymatic synthesis of O-acetyl-ADP-ribose and analogues thereof
#161Neuraminidase inhibitor compounds, compositions and methods for the use thereof in anti-viral treatments
#162Optically pure benzyl-4-chlorophenyl-C-glucoside derivative
#163Methods for inhibiting advanced glycation end product production, inhibiting fibroblast apoptosis, and/or promoting human fibroblast-collagen grating formulation using cherry blossom and cherry leaf extract
#164Method for 2-sulfation of glycosides
#1652,3-fluorinated glycosides as neuraminidase inhibitors and their use as anti-virals
#166Carbohydrate esters as inducers for gene expression
#167Polymer monoliths for solvent exchange in continuous flow microfluidic device
#168Synthetic intermediate of 1-(2-deoxy-2-fluoro-4-thio-β-D-arabinofuranosyl)cytosine, synthetic intermediate of thionucleoside, and method for producing the same
#169Glycodendrimers of polypropyletherimine
#170Chemoenzymatic methods for synthesizing moenomycin analogs
#171Dually derivatized chitosan nanoparticles and methods of making and using the same
#172Sialic acid analogs
#173Stabilisation of radiopharmaceutical precursors
#174Process for perparing fondaparinux sodium and intermediates useful in the synthesis thereof
#175Methods for making biocompatible polymerizable acrylate products
#176Synthetic heparin pentasaccharides
#177Aminoglycosides and uses thereof in treating genetic disorders
#178Isopropylmalate synthase from and methods and uses thereof
#179METHOD FOR MAKING A PRECURSOR OF L-FUCOSE FROM D-GLUCOSE
#180Process for producing novel sialo-sugar chain
#181Preparation of polyurethanes and polyesters from glycolipid type compounds
#182Chemoenzymatic synthesis of heparin and heparan sulfate analogs
#183Compositions, methods of synthesis and use of carbohydrate targeted agents
#184Low temperature, vacuum assisted chlorination of sucrose-6-esters free of overchlorinated by-products as intermediates for the production of the artificial sweetener, sucralose
#185Hybrid SCFA-hydroxyl-derivatized monosaccharides, methods of synthesis, and methods of treating disorders
#186Versatile native chemical ligation technologies
#187Selective glycosidase inhibitors and uses thereof
#188Diversification of human milk oligosaccharides (HMOs) or precursors thereof
#189Saccharide structures and methods of making and using such structures
#190Methods for the synthesis of functionalized nucleic acids
#191Preparation of poly alpha-1,3-glucan esters and films made therefrom
#192PREPARATION OF POLY ALPHA-1,3-GLUCAN ESTERS AND FILMS THEREFROM
#193Methods for pathogen detection and disease treatment
#194High performance acrylamide adhesives
#195Supramolecular nanofibers and hydrogels based on nucleic acids functionalized with nucleobases
#196Method for determining the presence or absence of a biomarker
#197Selective glycosidase inhibitors and uses thereof
#198PHARAMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING HUMAN IMMUNODEFICIENCY VIRUS
#199Biosynthesis of human milk oligosaccharides in engineered bacteria
#200Compounds and methods for chemical and chemo-enzymatic synthesis of complex glycans
#201N-substituted mannosamine derivatives, process for their preparation and their use
#2026″-amino-6″-deoxygalactosylceramides
#203Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation
#204Crystal of spiroketal derivatives and process for preparation of spiroketal derivatives
#205Selective glycosidase inhibitors and uses thereof
#206Efficient synthesis of ethylenedicysteine-sugar conjugates for imaging and therapy
#207Capillary electrophoresis method for fine structural analysis of enoxaparin sodium
#208Aminoglycosides and uses thereof in treating genetic disorders
#209Oligosaccharide mixture and food product comprising this mixture, especially infant formula
#210Chemical derivatives of jasmonate, pharmaceutical compositions and methods of use thereof
#211CARBOHYDRATE HAPTEN-BASED ANTI-CANCER VACCINES AND ANTIBODY DRUGS
#212Curcumin derivatives
#213Sialic acid analogs
#214Process for the recovery of beta acetylfuranoside
#215FATTY ACID AMIDES, COMPOSITIONS AND METHODS OF USE
#216Production of 6′-O-sialyllactose and intermediates
#217Glycosylated valproic acid analogs and uses thereof
#218Formulations from derivatives of curcumin, paclitaxel, and aspirin
#219Intermediates of 1-O-acyl-2-deoxy-2-fluoro-4-thio-beta-D-arabinofuranoses
#220PEROXIDE REMOVAL FROM DRUG DELIVERY VEHICLE
#221Method for preparation of the tetrasaccharide lacto-N-neotetraose (LNnt) containing N-acetyllactosamine
#222BLOCKERS OF PORE-FORMING VIRULENCE FACTORS AND THEIR USE AS ANTI-INFECTIVES
#223THERAPEUTIC PHARMACEUTICAL AGENT FOR DISEASES ASSOCIATED WITH DECREASE IN FUNCTION OF GNE PROTEIN, FOOD COMPOSITION, AND FOOD ADDITIVE
#224Biocompatible polymerizable acrylate products and methods
#225METHOD FOR SEPARATING SIALYLLACTOSE MATERIAL
#226Synthetic heparin disaccharides
#227Synthetic heparin trisaccharides
#228Biosynthesis of human milk oligosaccharides in engineered bacteria
#229ANTI-INFLUENZA AGENTS
#230Neuraminidase inhibitor compounds, compositions and methods for the use thereof in anti-viral treatments
#231Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation
#2322,3-fluorinated glycosides as neuraminidase inhibitors and their use as anti-virals
#233Carbohydrate-mediated tumor targeting
#234PROCESS FOR PREPARING PREGABALIN
#235KETOGENIC SACCHARIDES
#236ANTIBODIES DIRECTED TO TRA ANTIGENS, AND METHODS OF PRODUCTION, SCREENING AND ANALYSIS OF SAID ANTIBODIES, AS WELL AS METHODS OF ANALYSIS OF STEM CELLS AND CANCER CELL
#237Based-assisted formation of tin-sucrose adducts
#2386′-sialyllactose salts and process for their synthesis and for the synthesis of other alpha-sialyloligosaccharides
#239CERTAIN AMINOALKYL GLUCOSAMINIDE PHOSPHATE COMPOUNDS AND THEIR USE
#240HYDROPHOBIC POLYSACCHARIDES WITH PENDENT GROUPS HAVING TERMINAL REACTIVE FUNCTIONALITIES AND MEDICAL USES THEREOF
#241METHOD AND COMPOSITIONS
#242PROCESS FOR THE SYNTHESIS OF CLEISTANTHIN
#243Method of stimulating NKT with 6″-amino-6″-deoxygalactosylceramides
#244Glucosamine and glucosamine/anti-inflammatory mutual prodrugs, compositions, and methods
#245Crystal of spiroketal derivatives and process for preparation of spiroketal derivatives
#246Method for 2-sulfation of glycosides
#247Pharmaceutical composition comprising chito-oligomers
#248Trehalose compound, method for producing same, and pharmaceutical product containing the compound
#249Galactosylated pro-drugs of non-steroidal anti-inflammatories with improved pharmacokinetic characteristics and reduced toxicity of the starting drug
#250Hybrid SCFA-hydroxyl-derivatized monosaccharides, methods of synthesis, and methods of treating disorders
#251Saccharide structures and methods of making and using such structures
#252Anionic oligosaccharide conjugates
#253Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds
#254Hydrophobic polysaccharides with pendent groups having terminal reactive functionalities and medical uses thereof
#255Process for preparing substituted 1-O-acyl-2-deoxy-2-fluoro-4-thio-beta-D-arabinofuranoses
#256Process for preparing Fondaparinux sodium and intermediates useful in the synthesis thereof
#257Process for the production of sucrose-6-ester
#258Low temperature, single solvent process for the production of sucrose-6-ester
#259Alpha-selective sialyl phosphate donors for preparation of sialosides and sialoside arrays for influenza virus detection
#260Compounds
#261Glucose compound, cellulose composition, cellulose film, polarizing plate and liquid crystal display device
#262Lipid-drug conjugates for drug delivery
#263Galactose Alpha(1-3) Galactose Compositions
#264NOVEL PROCESS FOR THE RECOVERY OF BETA ACETYLFURANOSIDE
#265Monosaccharide compounds and methods therefor
#266Detection of oligosaccharides
#267Compound for denitrifying wastewater
#268NOVEL GLUCOPYRANOSE ESTERS AND GLUCOFURANOSE ESTERS OF ALKYL- FUMARATES AND THEIR PHARMACEUTICAL USE
#2696″-amino-6″-deoxygalactosylceramides
#270Bis-modified bicyclic nucleic acid analogs
#271Method for producing furanose derivative
#272Process for the preparation of compounds useful as inhibitors of SGLT
#273Process for making 5-azacytosine nucleosides and their derivatives
#274Stabilisation of radiopharmaceutical precursors
#275METHODS FOR EXTRACTING AND PURIFYING SUCRALOSE INTERMEDIATE
#276Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers
#277Ophthamological drugs
#278Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation
#279Removal of acids from tertiary amide solvents
#280GAMMA-HYDROXYBUTYRATE COMPOSITIONS CONTAINING CARBOHYDRATE, LIPID OR AMINO ACID CARRIERS
#281Fluorinated Carbohydrates and Their Use in Tumor Visualization, Tissue Engineering, and Cancer Chemotherapy
#282Synthetic heparin monosaccharides
#283Bis-modified bicyclic nucleic acid analogs
#284Process for the preparation of N-Acetyl-D-mannosamine monohydrate
#285Generation of Phosphorus Oxychloride as by-Product from Phosphorus Pentachloride and DMF and its Use for Chlorination Reaction by Converting Into Vilsmeier-Haack Reagent
#286Fluoridation Process
#287Oligosialic acid derivatives, methods of manufacture, and immunological uses
#288Method of fluorination
#289Acid Mediated Deacylation of 6-0-Trichlorogalactosurcrose to Trich-Lorogalactosucrose
#290Novel Glycopolymers, Uses Thereof, and Monomers Useful for Preparation Thereof
#291Method for synthesizing sucrose-6-acetic ester
#292Method of fluorination
#293Recombinant DNA molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections
#294Geranyl compounds
#295PROPHYLACTIC AND THERAPEUTIC TREATMENT OF INFECTIOUS AND OTHER DISEASES WITH MONO- AND DISACCHARIDE-BASED COMPOUNDS
#296Mevalonic acid derivatives
#297PROCESS FOR THE PREPARATION OF SUCROSE-6-ESTER BY ESTERIFICATION IN THE PRESENCE OF SOLID SUPERACID CATALYST
#298Processes for the production of aminoalkyl glucosaminide phosphate and disaccharide immunoeffectors, and intermediates therefor
#299Agents for therapy efficacy monitoring and deep tissue imaging
#300Conserved inner core lipopolysaccharide epitopes as multi-species vaccine candidates